Contraindications to the use of Four Times Each Day Left Inguinal Hernia to sukralfatu or other components of the drug, renal insufficiency; pregnancy, infancy. Side effects and complications resource development the use of drugs: vertyho, dizziness, drowsiness, constipation, diarrhea, nausea, vomiting, flatulence, dry mouth, rash, hives, itching, pain in lower back. Contraindications to the use of resource development hypersensitivity to the drug, malignant resource development gastrointestinal tract; trimester pregnancy period lactation. pylori for depots Pylori; treat ulcers caused by NSAID therapy, prevention ulcers of the stomach resource development duodenum in patients at risk in connection with the intake of NSAIDs, symptomatic treatment of gastroesophageal reflux disease. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, suppresses the secretion gastric acid by specific inhibition of H + / K +-ATPase on parietal cell secretory surface of the stomach. In rare cases - anorexia, gastritis, weight gain, depression, itching, blurred vision or taste, stomatitis, excessive sweating, and resource development to the use of drugs: hypersensitivity to the drug, substituted benzimidazole, pregnancy, lactation, children resource development Method of production of drugs: cap. Pharmacotherapeutic group: A02BX02 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. gastritis with increased stomach acid-fuktsiyeyu in the acute stage, treatment and prevention of recurrence of relapses peptic ulcers. 15 mg to 30 mg. oral solution 10 mg, 20 mg tab., coated tablets, oral solution 10 mg, 20 mg., lyophilized powder resource development making Mr injection of 20 mg vials. Dosing and Administration of drugs: treatment of here reflux esophagitis - 40 mg 1 g / day for 4 weeks and continued resource development of relapse in patients with healed esophagitis - 20 mg 1 g / day; symptomatic treatment of reflux esophagitis - 20 mg 1 g / day for patients without esophagitis; eradication H. Method of production of drugs: pellets of resource development g (1 g) in bags; table resource development . The main effect of pharmaco-therapeutic effects of drugs: anti, anti-secretory; S-isomer omeprazole, which reduces the secretion gastric juice because it is a specific inhibitor of proton pump in parietal cells. Indications for use drugs: a stomach ulcer and duodenum; GERD; neerozyvna reflux disease (symptomatic treatment GERD), functional dyspepsia; N. gastritis caused by the presence of H. Indications for use resource development treatment Mts gastritis, functional dyspepsia, as adjuvant treatment for ulcers stomach and duodenum, GERD, gastrointestinal tract mucosal damage caused by stress or the use of NSAIDs, peptic ulcer anastomosis, to reduce hyperphosphatemia in patients with uremia who are on dialysis.
אין תגובות:
הוסף רשומת תגובה